Ethical issues in oncology biostatistics
- 1 October 2002
- journal article
- research article
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 11 (5) , 429-448
- https://doi.org/10.1191/0962280202sm301ra
Abstract
A medical statistician’s routine professional activitiesare likely to have important ethical consequences. This is due in part to the fact that good medical practice and scientifically valid medical research both require as precursors high quality statistical design and data analysis. In this paper I discuss various ethical issues that I have encountered while working as a biostatistician at M.D. Anderson Cancer Center. I describe particular experiences and the ethical issues involved. Topics include medical decision making, benefit-harm tradeoffs, safety monitoring, adaptive randomization, informed consent, and publication bias.Keywords
This publication has 36 references indexed in Scilit:
- Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical TrialsJournal of the American Statistical Association, 2002
- Optimal two‐stage designs for clinical trials based on safety and efficacyStatistics in Medicine, 2001
- New directions in adaptive designsStatistical Science, 1996
- Bayesian sequential monitoring designs for single‐arm clinical trials with multiple outcomesStatistics in Medicine, 1995
- Investigating Therapies of Potentially Great Benefit: ECMOStatistical Science, 1989
- Incorporating Utility-Based Quality-of-Life Assessment Measures in Clinical TrialsMedical Care, 1989
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- The Two-Armed Bandit with Delayed ResponsesThe Annals of Statistics, 1988
- Hypothesis testing and sample size for bivariate binomial response in the comparison of two groupsJournal of Chronic Diseases, 1985
- ON THE LIKELIHOOD THAT ONE UNKNOWN PROBABILITY EXCEEDS ANOTHER IN VIEW OF THE EVIDENCE OF TWO SAMPLESBiometrika, 1933